Avoidance of EGFR impediments for patients with EGFR wild type/mutated NSCLC is normally characterized by “uninflamed” tumor microenvironment, weak immunogenicity, and immunological tolerance (86). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.